432 related articles for article (PubMed ID: 32565226)
41. Clinical course of coronavirus disease-2019 in pregnancy.
Pereira A; Cruz-Melguizo S; Adrien M; Fuentes L; Marin E; Perez-Medina T
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):839-847. PubMed ID: 32441332
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
[TBL] [Abstract][Full Text] [Related]
43. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.
Liang W; Liang H; Ou L; Chen B; Chen A; Li C; Li Y; Guan W; Sang L; Lu J; Xu Y; Chen G; Guo H; Guo J; Chen Z; Zhao Y; Li S; Zhang N; Zhong N; He J;
JAMA Intern Med; 2020 Aug; 180(8):1081-1089. PubMed ID: 32396163
[TBL] [Abstract][Full Text] [Related]
44. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy.
Morena V; Milazzo L; Oreni L; Bestetti G; Fossali T; Bassoli C; Torre A; Cossu MV; Minari C; Ballone E; Perotti A; Mileto D; Niero F; Merli S; Foschi A; Vimercati S; Rizzardini G; Sollima S; Bradanini L; Galimberti L; Colombo R; Micheli V; Negri C; Ridolfo AL; Meroni L; Galli M; Antinori S; Corbellino M
Eur J Intern Med; 2020 Jun; 76():36-42. PubMed ID: 32448770
[TBL] [Abstract][Full Text] [Related]
45. C-reactive protein and albumin association with mortality of hospitalised SARS-CoV-2 patients: A tertiary hospital experience.
Bannaga AS; Tabuso M; Farrugia A; Chandrapalan S; Somal K; Lim VK; Mohamed S; Nia GJ; Mannath J; Wong JL; Noufaily A; Disney BR; Arasaradnam RP
Clin Med (Lond); 2020 Sep; 20(5):463-467. PubMed ID: 32934038
[TBL] [Abstract][Full Text] [Related]
46. Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort study.
Berzuini C; Hannan C; King A; Vail A; O'Leary C; Brough D; Galea J; Ogungbenro K; Wright M; Pathmanaban O; Hulme S; Allan S; Bernardinelli L; Patel HC
BMJ Open; 2020 Sep; 10(9):e041983. PubMed ID: 32967887
[TBL] [Abstract][Full Text] [Related]
47. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
48. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
49. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
50. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
51. Insights from Italy: the Novara-COVID Score for rapid destination of COVID-19 patients at Emergency Department presentation.
Gavelli F; Castello LM; Patrucco F; Bellan M; Sainaghi PP; Avanzi GC
Minerva Med; 2020 Aug; 111(4):300-302. PubMed ID: 32407048
[No Abstract] [Full Text] [Related]
52. Associations between serum amyloid A, interleukin-6, and COVID-19: A cross-sectional study.
Liu Q; Dai Y; Feng M; Wang X; Liang W; Yang F
J Clin Lab Anal; 2020 Oct; 34(10):e23527. PubMed ID: 32860278
[TBL] [Abstract][Full Text] [Related]
53. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
54. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
[TBL] [Abstract][Full Text] [Related]
55. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
[TBL] [Abstract][Full Text] [Related]
56. Tocilizumab treatment in COVID-19: A single center experience.
Luo P; Liu Y; Qiu L; Liu X; Liu D; Li J
J Med Virol; 2020 Jul; 92(7):814-818. PubMed ID: 32253759
[TBL] [Abstract][Full Text] [Related]
57. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
[TBL] [Abstract][Full Text] [Related]
58. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.
Mishra V; Burma AD; Das SK; Parivallal MB; Amudhan S; Rao GN
Indian J Public Health; 2020 Jun; 64(Supplement):S221-S224. PubMed ID: 32496259
[TBL] [Abstract][Full Text] [Related]
59. Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection.
Gidari A; De Socio GV; Sabbatini S; Francisci D
Infect Dis (Lond); 2020 Oct; 52(10):698-704. PubMed ID: 32584161
[No Abstract] [Full Text] [Related]
60. Prevalence, clinical manifestations, and biochemical data of type 2 diabetes mellitus versus nondiabetic symptomatic patients with COVID-19: A comparative study.
Soliman AT; Prabhakaran Nair A; Al Masalamani MS; De Sanctis V; Abu Khattab MA; Alsaud AE; Sasi S; Ali EA; Ola A H; Iqbal FM; Nashwan AJ; Fahad J; El Madhoun I; Yassin MA
Acta Biomed; 2020 Sep; 91(3):e2020010. PubMed ID: 32921708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
